Jinan Bangwen Pharmaceutical Technology Co., Ltd., established on 2015-02-15, Business scope includes medical technology development;Chinese medicine products,Healthy food,Technology development of washing products,Technical Consulting and Technical Services;translation service;office services(Does not include engraved seal);data processing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mallinckrodt Hospital Products IP Unlimited Co., a subsidiary of Mallinckrodt Plc, is an Irish company located in Blanchardstown. The firm functions as an investment holding company.

Beijing Qi Yuan Yi De Pharmaceuticals Research Centre is a private company headquartered in Beijing, China, involved in pharmaceutical preparations.

We are advancing mRNA Lightning, a novel platform for the discovery of selective small molecule mRNA drugs and their mechanisms of action. Our differentiated approach combines high scale automated phenotypic screening in live biology with AI driven MOA elucidation of active compounds supported by Anima’s Compass MOAi technology. The high scale automation and integrated technologies in our platform enabled us to develop a broad pipeline across 18 different discovery programs in various therapeutic areas. With our deep expertise in mRNA biology and our Compass MOAi technology, we were able to advance them at unprecedented speed and success rate. In addition to our own pipeline, we established strategic collaborations with Pharma in partnered programs including our large scale collaborations with Lilly and Takeda Pharmaceuticals.

Mallinckrodt Pharmaceuticals Ireland Ltd., a subsidiary of Mallinckrodt Plc, is an Irish company that manufactures pharmaceutical products.

Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.

Hebei Ping An Health Group Co., Ltd., established on 2003-08-22, Business scope includes investment and investment management,consult;Realtor;medical service;Pension Service;medicine,medical instruments,Biotechnology,Health products,Food technology research and development,technical consulting,Technical Services,technology transfer;medicine,medical instruments,Health products,food sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Longhua Hospital Shanghai University of TCM, a subsidiary of Shanghai University of Traditional Chinese Medicine, is a company headquartered in Shanghai, China. The firm provides hospital services.

PharmaIN is a development stage biopharmaceutical company focused on enabling and improving injectable therapeutics based on the Protected Graft Copolymer (PGC™), our patented and proprietary drug delivery technology licensed from Massachusetts General Hospital. We are focused on half-life extension and targeted delivery of proteins, peptides, siRNA, and potent small molecule therapeutics.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Chengdu Jinrui Foundation Biotechnology Co., Ltd., established on 2009-05-12, Business scope includes licensed projects:Drug import and export;Drug Wholesale;Drug retail;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Socioeconomic Advisory Services;Technology Import and Export;Biochemical product technology research and development;Domestic trade agent;Health Consulting Services(Does not include medical services);business management;Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.

Guangdong Luofushan Sinopharm Co., Ltd., established on 2008-12-24, Business scope includes pharmaceutical production,Pharmaceutical business;Chinese herbal medicine acquisition;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Production and sales of disinfection products;Food production and sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of daily chemical products;Cosmetics Wholesale;Investment in pharmaceutical and other industries,Management and related consulting services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the manufacture, sale, research and development of household products and medical equipment. It also develops, manufactures, markets, and sells electro-medical equipment in the patient monitoring, laboratory instrument, and medical ultrasound fields. The company was founded by Hang Xu on January 25, 1991 and is headquartered in Shenzhen, China.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

China Food Peptide (Beijing) Biotechnology Co., Ltd., established on 2003-10-23, Business scope includes technology development,Technical Services,technical consulting;Import and export,Technology Import and Export,Agent import and export;Agricultural Science Research and Experimental Development;Sales instrumentation,Chemical Products(Free of chemical hazards),daily necessities,feed,medical instrumentsIkind,medical instrumentsIIkind;Production and processing of finalized packaged food(Limited to branch operations);sell food;Sales No.IIIclass of medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Sales No.IIIClass medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)